Early Therapeutic Drug Monitoring for Isoniazid and Rifampin among Diabetics with Newly Diagnosed Tuberculosis in Virginia, USA

Slow responders to tuberculosis (TB) treatment in Virginia have prolonged treatment duration and consume more programmatic resources. Diabetes is an independent risk factor for slow response and low serum anti-TB drug concentrations. Thus, a statewide initiative of early therapeutic drug monitoring...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Heysell, Scott K., Moore, Jane L., Staley, Debbie, Dodge, Denise, Houpt, Eric R.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2013
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3855970/
https://ncbi.nlm.nih.gov/pubmed/24349775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/129723
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados